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Abstract
We determined the capacity of transplanted beta cells to mod-
ify their replication and mass when stimulated by changes in
metabolic demand. Five groups of Lewis rats were studied:
group 1 (Tx-Px) had a 95% pancreatectomy 14 d after trans-
plantation of 500 islets; group 2 (Px-Tx) had a 95% pancreatec-
tomy 14 d before transplantation of 500 islets; group 3 (Tx)
was transplanted with 500 islets; group 4 (Px) had a 95% pan-
createctomy; and group 5 (normal) was neither transplanted
nor pancreatectomized. Blood glucose was normal in Tx-Px and
Tx groups at all times. Px-Tx and Px groups developed severe
hyperglycemia after pancreatectomy that was corrected in Px-
Tx group in 83% of rats 28 d after transplantation. Replication
of transplanted beta cells increased in Tx-Px (1.15±0.12%)
and Px-Tx (0.85±0.12%) groups, but not in Tx group
(0.64±0.07%) compared with normal pancreatic beta cells
(0.38±0.05%) (P < 0.001). Mean beta cell size increased in
Tx-Px (311±14 gm2) and Px-Tx (328±13 Mum2) groups com-
pared with Tx (252±12,tm2) and normal (239±9 Mm2) groups
(P < 0.001). Transplanted beta cell mass increased in Tx-Px
(1.87±0.51 mg) and Px-Tx (1.55±0.21 mg) groups compared
with Tx group (0.78±0.17 mg) (P < 0.05). In summary,
changes in transplanted beta cells prevented the development
of hyperglycemia in Tx-Px rats. Transplanted beta cells re-
sponded to increased metabolic demand increasing their beta
cell mass. (J. Clin. Invest. 1994. 93:1577-1582.) Key words:
diabetes * islet transplantation - beta cell growth * beta cell mass
* pancreatectomy
Introduction
The first successful transplants of islet cells in diabetic patients
have been reported recently (1-4). However, restoration of
normoglycemia is often not achieved or has limited duration.
The causes of the limited survival of transplanted islets in dia-
betic patients and in large animals (5) are not well understood.
In addition to rejection, nonimmunological factors could play
a role in these poor outcomes. For example, impaired growth
capacity of transplanted islets could lead to a decline in beta
cell mass and contribute to graft failure.
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A major problem in islet transplantation is obtaining suffi-
cient mass of islet tissue for transplantation. A critical islet
mass must be transplanted to achieve normoglycemia, with
continued success being dependent upon the number of ini-
tially transplanted islets (6-8). Moreover, the islet mass
needed for islet transplantation is higher that predicted on the
basis of beta cell measurements in diabetes (9). An unknown
factor in these considerations in the growth capacity of trans-
planted islets. Although some information about growth of
transplanted islets has been obtained over the past decade ( 10-
16), neither specific beta cell replication nor beta cell mass
have been determined. The implications ofchanges in beta cell
replication can only be understood when beta cell mass is also
taken into account.
We have shown that, in short-term successful islet trans-
plants, basal nonstimulated replication of transplanted beta
cells is similar to that ofendogenous pancreatic beta cells ( 17).
The aim of this study was to determine the capacity of trans-
planted beta cells to modify their replication and mass when
stimulated by changes in metabolic demand. We have used the
partial pancreatectomy model ( 18-21 ) to create a situation of
increased metabolic demand in rats with islet transplants in
order to determine the beta cell replicative capacity and the
changes of the transplanted beta cell mass.
Methods
Male Lewis rats (Harlan Sprague Dawley, Inc., Indianapolis, IN) were
obtained at 5 wk of age. Rats were transplanted with 500 syngeneic
islets under the kidney capsule, and/or underwent a 95% pancreatec-
tomy according to the protocol described below. Animals were bled
and weighed on the day oftransplantation, day ofpancreatectomy, and
at least on days 2, 5, 7, 10, 14, 18, 21, 25, and 28 after transplantation
and/or pancreatectomy. Blood glucose, determined between 9 and 11
a.m. in nonfasting conditions, was obtained from the snipped tail with
a heparinized microcapillary tube, and glucose was measured with a
portable glucose meter (Accu-Check II; Boehringer Mannheim Bio-
chemicals, Indianapolis, IN). Animals were kept under conventional
conditions in climatized rooms with free access to tap water and stan-
dard pelleted food.
Animal groups. Five experimental groups were studied (Table I).
Group 1 (n = 7): rats were transplanted and 14 d later underwent a
95% pancreatectomy (Tx-Px group); grafts and pancreatic remnants
were harvested 28 d after transplantation. Group 2 (n = 12): a 95%
pancreatectomy was performed and rats were transplanted 14 d later
(Px-Tx group); grafts and pancreatic remnants were harvested 14 (n
= 6) or 28 (n = 6) d after transplantation. Group 3 (n = 13): rats were
transplanted and grafts and pancreas were harvested 14 (n = 6) or 28 (n
= 6) d later (Tx group). Group 4 (n = 6): rats underwent 95% pancre-
atectomy and pancreatic remnants were harvested 14 d later (Px
group). Group 5 (n = 6): normal animals that had their pancreases
removed (normal group). The beta cell mass of 7 groups of 500 islets
isolated on different days was also determined. Since beta cell replica-
tion decreases with age (22), pancreatectomized groups were matched
for age at pancreatectomy (groups 1, 2, and 4) (7-8 wk old), and
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Table I. Experimental Groups
Group n DayO Day 14 Day 28 Day42
1 (Tx - Px) 7 Transplantation Pancreatectomy Harvest
2 (Px - Tx) 12 Pancreatectomy Transplantation Harvest (6) Harvest (6)
3 (Tx) 13 Transplantation Harvest (6) Harvest (7)
4 (Px) 6 Pancreatectomy Harvest
5 (Normal) 6 Harvest
Day 0 denotes the day when the first experimental procedure was performed in each group. Groups 1, 2, and 4 were matched for age at pancre-
atectomy and groups 3 and 5 had were matched for age at harvest with groups 1 and 4, and group 2 at day 28. Figures in parentheses in groups
2 and 3 show number of animals harvested at each time point.
groups 3 and 5 had the same age at harvest as groups 1 and 4. Rats were
transplanted with islets from 5-7-wk-old animals.
Islet isolation and transplantation. The method for islet isolation
and transplantation has been previously described for mice (17).
Briefly, under sodium amobarbital anesthesia, pancreases were dis-
tended with 6 ml of cold (40C) M-199 medium (GIBCO BRL, Gaith-
ersburg, MD) containing 2 mg/ml of collagenase (Collagenase from
Clostridium Histoliticum; Serva, Heidelberg, Germany), excised, and
incubated in a stationary bath at 370C. The islets were separated by a
density gradient (Histopaque-1077; Sigma Chemical Co., St. Louis,
MO) and isolated islets were hand picked under a stereomicroscope
two or three times until a population of pure islets was obtained. Only
islets > 75 and < 250 ,um in diameter were collected. With this restric-
tion the final yield was 200-250 islets per pancreas. The islets were
transplanted under the kidney capsule of the left kidney on the day of
the isolation using a 200-,ul pipette tip previously plugged with Gel-
foamO (Upjohn, Kalamazoo, MI).
Pancreatectomy. Partial pancreatectomy (95%) was performed in
7-8-wk-old rats as previously described ( 18). In brief, animals were
anesthetized with sodium amobarbital and 95% of the pancreas was
removed by gentle abrasion with cotton applicators, being careful to
leave major blood vessels intact. The pancreatic remnant was the tissue
between the common bile duct and the first loop of the duodenum.
Particular attention was placed on removing the small flap ofpancreas
attached to the pylorus. Nonpancreatectomized animals did not un-
dergo any sham operation.
Graft andpancreas removal. On the day of graft removal rats were
injected with 5-bromo-2'deoxyuridine (BrdU)' (Sigma Chemical
Co.), 100 mg/kg i.p. body weight, and 6 h later the graft was removed.
The kidney capsule surrounding the graft was incised and removed
with the graft. Usually all the graft was removed with the capsule; when-
ever the grafted islets were infiltrating the kidney cortex a second piece
of tissue was also taken to ensure that the entire graft was harvested.
The grafts were fixed in Bouin's solution and processed for plastic em-
bedding. The weight of the graft was determined on a balance reading
to 0.01 mg (A240; Mettler Instrument Corp., Hightstown, NJ) as de-
scribed ( 17). Immediately after graft removal, rats were killed and the
pancreas or the pancreatic remnants were excised, blotted, weighed,
and fixed in Bouin's solution. Subsequently, the pancreatic tissue was
embedded in paraffin.
Immunocytochemistry. Sections of graft and pancreas were double
stained for BrdU and for the endocrine nonbeta cells of the islets with
immunoperoxidase. Immunostaining for BrdU used a cell prolifera-
tion kit (Amersham International, Amersham, UK). Staining for the
endocrine nonbeta cells used a cocktail of antibodies: rabbit anti-bo-
vine glucagon (final dilution, 1:3,000; gift of Dr. M. Appel, University
of Massachusetts Medical School), rabbit antisynthetic somatostatin
(final dilution, 1:300; made in our own laboratory), and rabbit anti-
bovine pancreatic polypeptide, final dilution, 1:3,000; gift of Dr. R.
Chance, Eli Lilly & Co.).
1. Abbreviation used in this paper: BrdU, 5-bromo-2'deoxyuridine.
Beta cell replication, individual beta cell area, and beta cell mass.
Methods used for measurement of beta cell replication, area and mass
have been described in detail ( 17). For beta cell replication, beta cells
and BrdU-positive beta cells were counted using microscope (BH-2;
Olympus Corp., Lake Success, NY) connected to a video camera with a
black and white monitor. Results were expressed as the percentage of
BrdU-positive beta cells. At least 1,200 cells were counted per graft or
pancreas.
The mean cross sectional area of individual beta cells, a measure of
beta cell size, was determined on immunoperoxidase-stained sections
of grafts and isolated islets. For both grafts and isolated islets the beta
cell nuclei on a random field were counted and the area ofthe beta cell
tissue in that field measured with an electronic planimetry program
(Sigma Scan; Jandel Scientific, Corte Madera, CA). The beta cell area
was divided by the number ofbeta cell nuclei to calculate the area ofthe
individual beta cells. As pointed out previously ( 17), the actual num-
ber ofbeta cells was higher than the number counted, since not all beta
cells were sectioned across their nuclei and, therefore, the size of the
beta cells was overestimated.
Beta cell mass was measured by point counting morphometry on
immunoperoxidase-stained sections ofgraft and endogenous pancreas.
Each section was covered systematically using a 48-point grid to obtain
the number of intercepts over beta cells, over endocrine nonbeta cells,
and over other tissue. In pancreatic sections intercepts over exocrine
tissue and over nonpancreatic tissue were counted separately. The beta
cell relative volume was calculated by dividing the intercepts over beta
cells by intercepts over total tissue; then the beta cell mass was esti-
mated by multiplying beta cell relative volume by graft weight. Endo-
crine nonbeta cell mass and pancreatic exocrine mass were obtained in
the same way. The beta cell mass of the islets at the time of the trans-
plantation was determined in 7 groups of500 islets isolated on different
days. Beta cell mass was obtained by multiplying the weight ofthe islets
by the percentage ofbeta cell volume as derived from our data (92.7%).
Statistical analysis. Results were expressed as mean and standard
error of the mean (x+±SEM). For comparisons between two groups the
unpaired Student's t test (two tailed) was used and for multiple compar-
isons the one-way analysis of variance (ANOVA) was used. A P value
of < 0.05 was considered significant.
Results
Metabolic evolution after transplantation and
pancreatectomy
The body weight and blood glucose at critical time points
(transplantation, pancreatectomy, and harvesting) are shown
in Table II. The evolution of blood glucose throughout the
experiment is summarized in Fig. 1. Pancreatectomy induced
severe hyperglycemia in Px-Tx and Px groups. In contrast, in
Tx-Px group hyperglycemia was prevented by the previous
transplantation of 500 islets. Blood glucose in this group was
not different from glucose in normal group or Tx group during
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Table IL Metabolic Characteristics ofExperimental Groups at Different Time Points
Day of transplantation Day of pancreatectomy Day of harvesting
Body Blood Body Blood Body Blood
Group weight glucose weight glucose weight glucose
g mmol/liter g mmol/liter g mmol/liter
1 (Tx + Px) 130±7 6.11±0.3 228±6 6.11±0.3 269±10 6.44±0.3
2 (Px + Tx) 255±3 18.8±0.9 218±3 6.22±0.2 308±6 9.78±1.8
3 (Tx) 117±5 5.17±0.2 245±10 5.83±0.2
4 (Px) 202±4 6.50±0.2 254±9 14.5±0.2
5 (normal) - 279±11 6.28±0.2
For groups 2 and 3 the values show mean body weight and blood glucose ofanimals killed 14 and 28 d after transplantation. Results are expressed
as mean±SEM.
the follow up. One rat, however, developed transient moderate
hyperglycemia (blood glucose, 10.2 mM/liter). Transplanta-
tion in already pancreatectomized rats (Px-Tx group) restored
euglycemia (blood glucose, < 7.2 mM/liter; mean plus 2 SD of
blood glucose in normal group) in 7 of 12 rats 14 d after Tx and
in 5 of 6 rats 28 d after transplantation.
Beta cell replication
Transplanted beta cells. As shown in Fig. 2, beta cell replication
was increased in transplanted islets from Tx-Px group
(1.15±0.12%) compared with pancreatic islets from normal
group (0.38±0.05%) and with transplanted beta cells from Px-
Tx group (0.56±0.09%) and Tx group (0.64±0.07%) (P
< 0.001 ). Replication was not statistically different in Px-Tx,
Tx, and normal groups. However, in Px-Tx groups, when day
28 and 42 grafts were considered separately, replication was
increased at day 28 (0.81±0.12%) compared with day 42
(0.33±0.04%) and with normal pancreatic islets (P < 0.001).
Replication was similar in Tx group at days 14 and 28 after
transplantation.
Endogenous pancreas. As shown in Fig. 3, in Tx-Px group
beta cell replication in the pancreatic remnant was increased
( 1.01±0.25%) compared with Px-Tx group (0.49±0.11%), Tx
group (0.40±0.1 1%), Px group (0.65±0.18%), and normal
group (0.38±0.05%) (P < 0.05). When experimental animals
were analyzed individually, it was apparent that replication in
transplanted beta cells and in pancreatic beta cells was similar
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Figure 1. Evolution of fed blood glucose in experimental groups.
Groups are described in Table I. Values are mean±SEM.
and the presence of a positive correlation between replication
in both locations was established (r = 0.55, P = 0.003). How-
ever, in Px-Tx group replication was increased on day 28 in
transplanted beta cells (0.81±0.12%) but not in pancreatic beta
cells (0.55±0.18%). The discrepancy between replication in
endogenous and transplanted islets in this group could reflect
the different exposure to hyperglycemia, < 14 d in transplanted
islets and > 21 d in the endogenous islets ( 17);.
Beta cell area
As shown in Fig. 4, the individual cross sectional area of beta
cells in isolated islets was 239±10 4Mm2. Beta cell size was in-
creased in transplanted islets from Tx-Px group (311± 14 1Im2)
and Px-Tx group (328±13 1Im2) compared with nonpancre-
atectomized group (Tx group: 252±12 Rm2) or with beta cell
area in isolated islets (P = 0.001 ).
Beta cell mass
Transplanted islets. As shown in Fig. 5, transplanted beta cell
mass increased in Tx-Px (1.81±0.51 mg) and Px-Tx
(1.55±0.21 mg) rats compared with nonpancreatectomized
animals (Tx group: 0.78±0.17 mg) (P < 0.05). In Tx group
one outlying value (higher than mean plus 2.5 SD) was ex-
1,4 *
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Normal Tx-Px Px-Tx Tx
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Figure 2. Beta cell replication in normal pancreas and in transplanted
islets. Replication is expressed as percentage of BrdU-positive beta
cells. Names on the x-axis correspond to groups shown in Table I.
Values are mean±SEM. *P < 0.001 between Tx-Px group and all
other groups.
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Figure 3. Beta cell replication in endogenous pancreatic beta cells.
Replication is expressed as percentage of BrdU-positive beta cells.
Names on the x-axis correspond to groups shown in Table I. Values
are mean±SEM. *P < 0.001 between Tx-Px group and all other
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Figure 5. Transplanted beta cell mass. Groups on the x-axis corre-
spond to those described in Table I. Isolated islets show the initially
transplanted beta cell mass. Values are mean±SEM. *P < 0.05, be-
tween Tx-Px and Px-Tx groups and Tx group.
cluded. Beta cell mass in Tx group grafts was reduced to 74% of
the initially transplanted beta cell mass (1.05±0.07 mg, P
=NS).
Endogenous pancreas. Beta cell mass was not significantly
different among the remnants of the three pancreatectomized
groups or between the two nonpancreatectomized groups, de-
spite the different protocols for transplantation (Table III).
Beta cell mass in pancreatic remnants of Tx-Px and Px-Tx
groups increased to 23 and 19%, respectively, of the total beta
cell mass in normal pancreases. In Px group the value repre-
sented 42% ofthe beta cell mass in normal pancreases. Beta cell
mass in Tx group was similar to that of normal rats.
To compare the beta cell volume in the pancreas of all five
groups beta cell mass was expressed per gram of pancreas (Ta-
ble III). Beta cell relative volume was increased in Px group
compared with all other groups.
Endocrine nonbeta cells and exocrine pancreas mass
Differences in endocrine nonbeta cell mass of transplanted is-
lets among groups did not reach statistical significance (results
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Figure 4. Area of individual beta cells from isolated and transplanted
islets. Groups on the x-axis correspond to those described in Table
I. Isolated islets show beta cell area on the transplantation day. Values
are mean±SEM. *P < 0.001 between Tx-Px and Px-Tx groups and
isolated islets and Tx groups.
not shown). Endocrine nonbeta cell mass in Tx-Px and Px-Tx
groups was - 10% that of normal pancreas. No differences
were seen between Tx and normal groups.
The exocrine tissue showed a significant regeneration in
pancreatectomized groups (Table III), attaining 15-17% ofthe
exocrine mass in the normal group instead ofthe 5% remaining
after surgery. The mass of exocrine tissue in the pancreatic
remnant was similar in all three pancreatectomized groups,
confirming that the extent ofpancreatectomy was similar in all
groups.
Discussion
Beta cells transplanted into normal rats increased their replica-
tion and size when a 95% pancreatectomy was performed (Tx-
Px group), and total beta cell mass almost tripled. Similar re-
sults were obtained when islets were transplanted into already
pancreatectomized rats (Px-Tx group). However, although
normoglycemia was maintained in Tx-Px rats after pancreatec-
tomy, it took several days to restore it in Px-Tx group and in
some cases this was not achieved. Beta cell response to pancre-
atectomy in the grafted islets was similar to that of islets in the
endogenous pancreas, indicating that normal growth capacity
was preserved in beta cells after transplantation.
Table III. Endocrine and Exocrine Mass in Pancreas
and Pancreatic Remnants
Exocrine Relative beta
Group Beta cell Nonbeta cell pancreas cell volume
mg mg mg
1 (Tx - Px) 1.08±0.26 0.15±0.05 152±12 6.95±1.70
2 (Px - Tx) 0.87±0.25 0.13±0.04 171±10 4.83±1.30
3 (Tx) 5.09±0.59 1.29±0.16 913±30 5.55±0.58
4 (Px) 1.99±0.75 0.22±0.05 150±14 12.3±3.84*
5 (normal) 4.68±0.65 1.48±0.26 977±30 4.81±0.65
Relative beta cell volume is beta cell mass per gram of pancreas. Val-
ues are mean±SEM. * P < 0.05 compared with all other groups.
1580 E. Montafla, S. Bonner-Weir, and G. C. Weir
The increase in replication and size of transplanted beta
cells after pancreatectomy in Tx-Px rats resulted in increased
beta cell mass. The severe hyperglycemia that followed pancre-
atectomy in Px and Px-Tx groups was prevented in Tx-Px rats
by the transplantation of 500 islets. Thus, transplanted beta
cells were able to compensate for the increased metabolic de-
mand placed upon them by the surgical reduction of endoge-
nous beta cell mass. It is not clear, however, how beta cells
sensed this increased metabolic demand. The concept ofadap-
tive beta cell proliferation has been used to suggest that func-
tional demand is a mechanism of control of beta cell replica-
tion (23). Glucose is awell-known stimulus forbeta cell replica-
tion both in vitro (22, 24) and in vivo (25), and hyperglycemia
is present in most of the conditions in which adaptive beta cell
proliferation occurs. However, hyperglycemia was not detected
in Tx-Px group. The results resemble the islet growth described
in other situations ofincreased metabolic demand where hyper-
glycemia is not detected, such as 40 and 60% pancreatectomies
(20, 21 ) or pregnancy (26). Subtle elevations in blood glucose
could have been responsible for increased beta cell replication
in Tx-Px rats. Moreover, in addition to glucose, other media-
tors may also have contributed to increase beta cell prolifera-
tion. The identification ofthese mediators could open the possi-
bility for interventions to modulate the growth of transplanted
beta cells.
When islets were transplanted into already pancreatecto-
mized rats (Px-Tx group) beta cell replication and size in-
creased and beta cell mass doubled 14 d after transplantation.
However, although transplanted and endogenous beta cell
mass were similar in Tx-Px and Px-Tx groups, normoglycemia
was sustained in Tx-Px rats throughout the follow up while its
restoration was delayed, and in some case even not achieved, in
Px-Tx rats. Since pancreatectomy in Tx-Px group was per-
formed 14 d after transplantation, one could wonder whether
an increase in grafted beta cell mass during that period was
responsible for the maintenance of normoglycemia after pan-
createctomy. The question was addressed by the measurement
of beta cell mass in Tx group 14 d after transplantation. Beta
cell mass in this group was found to be 74% of that initially
transplanted, ruling out the possibility ofan increased beta cell
mass in Tx-Px rats at the time of pancreatectomy. The reduc-
tion confirms our previous results in mice showing that trans-
plantation of islets into normal recipients results in a decreased
beta cell mass in the graft after transplantation ( 17). Endoge-
nous beta cell mass in the pancreas remnant was also similar in
Tx-Px and Px-Tx rats. The extent of pancreatectomies was
equivalent in both groups, as confirmed by the amount of exo-
crine tissue found at the end of follow up. Therefore, factors
other than the absolute beta cell mass contributed to differ-
ences in blood glucose in these two groups. The previous obser-
vation that maintenance of normoglycemia may require a
lower beta cell mass than its restoration (27) agrees with our
current results in that a similar beta cell mass was able to sus-
tain normoglycemia in Tx-Px rats but not to restore it in Px-Tx
rats. Hyperglycemia, which is associated with insulin resis-
tance, could have contributed to the differences in beta cell
mass requirement. In addition, vascularization could have also
played a role in the different evolution. It has been shown that
transplanted islets are fully vascularized 10 d after transplanta-
tion (28, 29), and therefore islets transplanted into Tx-Px rats
were well vascularized at the time of pancreatectomy. In con-
trast, the islets transplanted into Px-Tx rats were confronted
with hyperglycemia at the time of transplantation, when they
had deficient vascularization. Impaired vascularization could
reduce beta cell capacity to sense and respond to increased
metabolic demand, and therefore decrease the functional beta
cell mass. In a situation such our experimental groups, where
only a marginal islet mass was transplanted (30, 31 ), vascular-
ization of islets could have been crucial for an appropriate re-
sponse to changes in metabolic conditions. Therefore, the de-
layed but eventual achievement ofnormoglycemia in most rats
of Px-Tx group may have resulted from the combination of
progressive increase in beta cell mass after transplantation and
restoration of islet vascularization.
Beta cell replication and beta cell mass were also increased
in the pancreatic remnant ofTx-Px and Px-Tx groups. Replica-
tion in transplanted and endogenous beta cells showed a good
correlation in all three transplanted groups, suggesting that the
responsiveness of transplanted beta cells was normal. The one
exception was Px-Tx group 14 d after transplantation when
beta cell replication was increased in the graft but not in the
pancreatic remnant. The discrepancy could be due to different
exposure times to severe hyperglycemia: > 21 d for endoge-
nous pancreatic beta cells and < 14 d for transplanted beta
cells. We have previously reported that the increased beta cell
replication accompanying hyperglycemia did not persist when
exposure to severe hyperglycemia became chronic ( 17 ). Simi-
larly, replication was not significantly increased in Px rats in a
situation of chronic severe hyperglycemia, suggesting again a
limitation of beta cell replication.
Both beta cells and exocrine pancreas underwent signifi-
cant regeneration after pancreatectomy. Beta cell mass and exo-
crine mass increased to a similar extent in Tx-Px and Px-Tx
groups as shown by the preservation of the ratio between beta
cell mass and pancreatic mass. The increase in exocrine tissue
in Px group was equivalent to that in the other pancreatecto-
mized groups, but beta cell mass increased more markedly in
this nontransplanted group. Perhaps the presence of trans-
planted beta cells restrained the increase of endogenous beta
cell mass in Tx-Px and Px-Tx groups.
The capacity of transplanted beta cells to respond to
changes in metabolic demand and the similarity between their
replicative response and that of endogenous nontransplanted
beta cells have important implications for islet transplantation.
In clinical transplantation, different factors may modify the
metabolic demand placed on transplanted beta cells. For in-
stance, episodes of acute rejection decrease the transplanted
beta cell mass and higher doses of immunosuppressive drugs
can increase insulin resistance and impair beta cell function or
islet cell DNA replication (32, 33). It is therefore encouraging
to find that transplanted beta cells are able to respond effec-
tively to severe reductions in beta cell mass. Moreover, if the
transplantation method could be optimized it may be possible
to obtain a successful result with a smaller number of islets,
thus alleviating the islet shortage that limits current transplan-
tation efforts.
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